C
Caris Life Sciences Inc
NASDAQ:CAI
Caris Life Sciences Inc
NASDAQ:CAI
Price:
19.22
USD
-5.83%
Market Closed
Market Cap:
$5.4B
Balance Sheet
Balance Sheet Decomposition
Caris Life Sciences Inc
Caris Life Sciences Inc
Balance Sheet Decomposition is not available for
Caris Life Sciences Inc
Caris Life Sciences Inc
Balance Sheet
Caris Life Sciences Inc
Caris Life Sciences Inc
Currency:
| Dec-2023 | Dec-2024 | ||
|---|---|---|---|
| Assets | |||
| Cash & Cash Equivalents |
60
|
65
|
|
| Cash Equivalents |
60
|
65
|
|
| Short-Term Investments |
65
|
2
|
|
| Total Receivables |
55
|
88
|
|
| Accounts Receivables |
55
|
88
|
|
| Other Receivables |
0
|
0
|
|
| Inventory |
49
|
40
|
|
| Other Current Assets |
13
|
20
|
|
| Total Current Assets |
243
|
216
|
|
| PP&E Net |
107
|
68
|
|
| PP&E Gross |
107
|
68
|
|
| Accumulated Depreciation |
184
|
229
|
|
| Goodwill |
19
|
19
|
|
| Other Long-Term Assets |
44
|
41
|
|
| Other Assets |
19
|
19
|
|
| Total Assets |
413
N/A
|
344
-17%
|
|
| Liabilities | |||
| Accounts Payable |
27
|
28
|
|
| Accrued Liabilities |
58
|
65
|
|
| Short-Term Debt |
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
60
|
|
| Other Current Liabilities |
11
|
12
|
|
| Total Current Liabilities |
95
|
165
|
|
| Long-Term Debt |
166
|
319
|
|
| Other Liabilities |
171
|
136
|
|
| Total Liabilities |
433
N/A
|
621
+44%
|
|
| Equity | |||
| Common Stock |
2 125
|
2 222
|
|
| Retained Earnings |
2 119
|
2 472
|
|
| Additional Paid In Capital |
0
|
0
|
|
| Treasury Stock |
0
|
0
|
|
| Other Equity |
25
|
26
|
|
| Total Equity |
20
N/A
|
277
-1 309%
|
|
| Total Liabilities & Equity |
413
N/A
|
344
-17%
|
|
| Shares Outstanding | |||
| Common Shares Outstanding |
278
|
278
|
|
Switch to:
Switch to:
See Also
Discover More
